Xylazine, veterinary anesthetic and recreational drug adulterant, reduces cephalic regeneration and alters defensive responding in planarians
Authors:
- Amy D. StringerASAmy D. Stringer
- Meghana DachepalliMDMeghana Dachepalli
- Scott M. RawlsSRScott M. Rawls
- 14 August 2026
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 116
Abstract
No abstract availableFunding Information
- National Institute on Drug Abuse
- National Institutes of Health (R21DA062400)
- National Institutes of Health (T32DA007237-35)
This publication has 53 references indexed in Scilit:
- Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonismAddiction Neuroscience, 2024
- Xylazine: A Drug Adulterant of Clinical ConcernCurrent Pain and Headache Reports, 2024
- Xylazine effects on opioid-induced brain hypoxiaPsychopharmacology, 2023
- Conditioned place avoidance in the planaria Schmidtea mediterranea: A pre-clinical invertebrate model of anxiety-related disordersBehavioural Processes, 2023
- Insights into the histology of planarian flatworm Phagocata gracilis based on location specific, intact lipid information provided by GCIB-ToF-SIMS imagingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Alpha2-adrenergic agonists for the management of opioid withdrawalCochrane Database of Systematic Reviews, 2016
- Evidence of Nicotine-Induced, Curare-Insensitive, Behavior in PlanariansNeurochemical Research, 2015
- Xylazine-evoked depression of rat cerebral cortical neurons: a pharmacological studyGeneral Pharmacology: The Vascular System, 1989
- Effects of dopaminergic agents on monoamine levels and motor behaviour in planariaComparative Biochemistry and Physiology Part C: Comparative Pharmacology, 1983
- Clonidine analgesia and suppression of operant responding: Dissociation of mechanismEuropean Journal of Pharmacology, 1981